期刊文献+

四甲基吡嗪衍生物合成及其5-HT_3受体拮抗活性的筛选 被引量:3

Synthesis of the Derivatives of Tetramethylpyrazine and Screening for 5-HT_3 Receptor Antagonistic Activity
下载PDF
导出
摘要 According to the principle of bioisosterism and the Evans′pharmacophore model of 5-HT3 receptor antagonists, twelve derivatives of tetramethylpyrazine were synthesized. The structures of the compounds were confirmed by MS, 1H NMR and HRMS. All the target compounds are unreported. The preliminary activity test showed that most of the compounds had fairly potent 5-HT3 receptor antagonistic activities, especially compound 3c. And the conformational analysis showed that the active conformation of the compounds was quite fitted to the Evans′pharmacophore model. This indicates that besides the three pharmacophoric elements, the aromatic ring and the substituents attached may affect the bioactivities of the compounds. According to the principle of bioisosterism and the Evans′pharmacophore model of 5-HT_3 receptor antagonists, twelve derivatives of tetramethylpyrazine were synthesized. The structures of the compounds were confirmed by MS, ~ 1H NMR and HRMS. All the target compounds are unreported. The preliminary activity test showed that most of the compounds had fairly potent 5-HT_3 receptor antagonistic activities, especially compound 3c. And the conformational analysis showed that the active conformation of the compounds was quite fitted to the Evans′pharmacophore model. This indicates that besides the three pharmacophoric elements, the aromatic ring and the substituents attached may affect the bioactivities of the compounds.
机构地区 复旦大学药学院
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2005年第4期683-685,共3页 Chemical Journal of Chinese Universities
关键词 四甲基吡嗪衍生物 5-HT3受体拮抗剂 构效关系 Derivatives of tetramethylpyrazine 5-HT_3 Receptor antagonistic inhibitor Structure-activity relationship(SAR)
  • 相关文献

参考文献9

  • 1全哲山,朴虎日,金光男,孙振学.替硝唑的合成[J].延边医学院学报,1994,17(1):30-31. 被引量:4
  • 2陈学敏,许淑菊,马永雯.2─羟甲基─3,5,6─三甲基吡嗪的合成及其对血液流变性的影响[J].中国药物化学杂志,1996,6(4):254-256. 被引量:15
  • 3Fozard J. R., Mobarok Ali A. T. M., Newgrosh G.. Brit. J. Pharmacol.[J]. 1977, 61: 130-135.
  • 4Fozard J. R., Mobarok Ali A. T. M.. Brit. J. Pharmacol.[J]. 1978, 49: 109-112.
  • 5Kato S., Fujiwara I., Yoshida N.. Med. Res. Rev.[J]. 1999, 21: 47-73.
  • 6Evans S. M., Galdes A., Gall M. et al.. Pharmacology Biochemistry & Behavior[J]. 1991, 40: 2721-2726.
  • 7Yoshida T., Matsuura N., Yamamoto K. et al.. Heterocycles[J]. 1996, 43(12): 2701-2712.
  • 8Harada H., Morie T., Hirokawa Y. et al.. Chem. Pharm. Bull.[J]. 1996, 44(12): 2205-2212.
  • 9Hassner A., Alexanian V.. Tetrahedron Lett.[J]. 1978, 46: 4475-4478.

二级参考文献5

  • 1江骥,姜国辉,叶云鹏,王世真.川芎嗪的体内代谢[J].中国医学科学院学报,1993,15(2):79-82. 被引量:25
  • 2楼雅卿,张宏,曹霞,陈孟来.磷酸川芎嗪在狗和大鼠的药代动力学和体内命运[J]药学学报,1986(07).
  • 3聂松青,谢宗岑,林克椿.川芎嗪对兔血小板膜流动性、电泳迁移率的影响及其与抗凝作用的关系[J]药学学报,1985(09).
  • 4郭占忠,刘占儒.二十四种中药对血液粘度直接影响的观察[J]中医药学报,1984(05).
  • 5宫伟星.川芎嗪心血管药理的研究进展[J].中国医院药学杂志,1990,10(11):511-512. 被引量:85

共引文献17

同被引文献24

  • 1程先超,刘新泳,徐文方.川芎嗪的结构改造及修饰[J].药学进展,2005,29(6):241-246. 被引量:16
  • 2王艳萍,李文兰,范玉奇.川芎嗪药理作用的研究进展[J].药品评价,2006,3(2):144-146. 被引量:72
  • 3黎艳玲,杨华武,陈雄,赵瑜,周宇,银董红.2,6-脱氧果糖嗪的分离提纯及其向烟气释放致香成分的研究[J].中国烟草学报,2007,13(3):32-34. 被引量:4
  • 4杨楚耀 黄新明.2-溴甲基-3,5,6-三甲基吡嗪及其衍生物的制备[J].复旦学报:自然科学版,1980,19(4):390-393.
  • 5Iizuka K, Akahane K, Momose D, et al. Highyl selective inhibitors of thromboxane synthetase. 1. Imidazole derivatives[ J ]. J Med Chem, 1981,24 ( 10 ) : 1139 - 1148.
  • 6杨楚耀 黄新明.复旦大学学报:自然科学版,1980,19:390-390.
  • 7Gao, Y.; Voigt, J.; Zhao, H.; Pais, G. C. G.; Zhang, X.; Wu, L.; Zhang, Z. -Y.; Burke, T. R., Jr. J. Med. Chem. 2001, 44, 2869.
  • 8黄枕亚.药物化学进展,化学工业出版社,北京,2001,pp.39-69.
  • 9Chackalamannil, S. J. Med. Chem. 2006, 49, 5389.
  • 10Iizuka, K.; Akahane, K.; Momose, D.; Nakazawa, M. J. Med. Chem. 1981, 24, 1139.

引证文献3

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部